Multiple Symmetric Lipomatosis: A Cross-Sectional Study to Investigate Clinical Features and Patients' Quality of Life
暂无分享,去创建一个
Michael Koller | Stephan Schreml | Lukas Prantl | Daniel Schiltz | Karolina Mueller | Christine Ortner | Sebastian Tschernitz | Alexandra Anker | Oliver Felthaus | Julia Schreml | M. Koller | L. Prantl | S. Schreml | J. Schreml | D. Schiltz | A. Anker | Karolina Mueller | O. Felthaus | S. Tschernitz | C. Ortner
[1] H. Reichmann,et al. Neurological multisystem manifestation in multiple symmetric lipomatosis: A clinical and electrophysiological study , 1995, Muscle & nerve.
[2] A. Hirose,et al. Benign symmetric lipomatosis associated with alcoholism. , 2006, Internal medicine.
[3] K. Boycott,et al. Homozygous mutations in MFN2 cause multiple symmetric lipomatosis associated with neuropathy. , 2015, Human molecular genetics.
[4] J. Li,et al. The endocrine and metabolic evaluation of benign symmetrical lipomatosis: a case report and literature review. , 2010, Neuro endocrinology letters.
[5] R. Kessler,et al. Self-Reported Population Health: An International Perspective based on EQ-5D , 2014, Springer Netherlands.
[6] O. Braun-falco,et al. [Benign symmetric Launois-Bensaude type III lipomatosis and Bureau-Barrière syndrome]. , 1991, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.
[7] Jun Wang,et al. [Recent progress on diagnosis and treatment of benign symmetric lipomatosis]. , 2010, Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery.
[8] M. Augustin,et al. Dimensions of patient needs in dermatology: subscales of the patient benefit index , 2010, Archives of Dermatological Research.
[9] M. Augustin,et al. Evaluation of patient-relevant outcomes of lymphedema and lipedema treatment: development and validation of a new benefit tool. , 2014, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.
[10] G. Enzi. Multiple Symmetric Lipomatosis: An Updated Clinical Report , 1984, Medicine.
[12] J. Granneman,et al. Adipose tissue plasticity from WAT to BAT and in between. , 2014, Biochimica et biophysica acta.
[13] G. Sergi,et al. Multiple symmetric lipomatosis: a rare disease and its possible links to brown adipose tissue. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[14] J. M. Puebla,et al. Madelung's disease. , 2013 .
[15] E. Nisoli,et al. Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells , 2002, The Journal of pathology.
[16] S. Berkovic,et al. Multiple Symmetrical Lipomatosis--a mitochondrial disorder of brown fat. , 2013, Mitochondrion.
[17] Y. Bae,et al. Characterization and Expression Analysis of Mesenchymal Stem Cells from Human Bone Marrow and Adipose Tissue , 2004, Cellular Physiology and Biochemistry.
[18] M. Correia,et al. Madelung’s Disease: Revision of 59 Surgical Cases , 2017, Aesthetic Plastic Surgery.
[19] J. Cameselle-Teijeiro,et al. Madelung’s Disease: Comorbidities, Fatty Mass Distribution, and Response to Treatment of 22 Patients , 2013, Aesthetic Plastic Surgery.
[20] Calcyphosine-like (CAPSL) is regulated in Multiple Symmetric Lipomatosis and is involved in Adipogenesis , 2019, Scientific Reports.
[21] L. Prantl,et al. Adipose Tissue in Multiple Symmetric Lipomatosis Shows Features of Brown/Beige Fat , 2020, Aesthetic Plastic Surgery.
[22] G. Enzi,et al. Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study , 2002, International Journal of Obesity.
[23] A. Garg,et al. Homozygous LIPE mutation in siblings with multiple symmetric lipomatosis, partial lipodystrophy, and myopathy , 2017, American journal of medical genetics. Part A.
[24] W. Greiner,et al. Validating the EQ-5D with time trade off for the German population , 2005, The European Journal of Health Economics.